Jones Day has advised Analyte Health, Inc. in its collaboration with Teladoc to integrate lab testing with telemedicine-delivered patient services.
The partnership has been billed as a complete integration of doctors, patients and labs in a virtual environment.
The collaboration, which should be in full swing by April, will allow Teladoc physicians to connect patients with an Analyte technician in their area to collect the blood or specimen sample needed to confirm a diagnosis. Results are electronically available to physicians and patients within one to three days.
Analyte will provide lab services for chronic and acute care, behavioral health and preventive health services. Analyte has more than 1,000 locations with sites in all 50 states.
Plans call for expanding services to include in-home testing, which Analyte already does for patients getting tests for sexually transmitted diseases. Home testing involves having a technician come to the patient’s location but is still less expensive than a visit to an urgent care center, Analyte CEO Frank Cockerill, said in an interview.
Teladoc recently announced that it had recorded its 2 millionth patient visit. It also released findings of a study it commissioned that was led by Harvard Medical School and Brigham and Women’s Hospital researcher Dr. Niteesh Choudhry which found thatthe 2 million Teladoc visits generated a total savings of $900 million to the healthcare system.
Jones Day has advised Analyte Health, Inc. on the deal with a team led by partner Alexis Gilroy.
Involved fees earner: Alexis Gilroy – Jones Day;
Law Firms: Jones Day;
Clients: Analyte Health, Inc.;